Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
terminated

Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients

key information

study id #: NCT00151476

condition: Familial Adenomatous Polyposis (FAP)

status: terminated

purpose:

This is a registry-based observational study assessing clinical outcomes in FAP patients receiving celecoxib compared with historical/concurrent registry patients who have not received celecoxib.

Both retrospective and prospective data will be utilized. No sampling methods apply.

intervention: Drug: Celecoxib
Other: Routine Medical Care

To improve your experience on this site we use cookies. This includes cookies essential for the basic functionalities of our website, cookies used for analytical purposes and cookies enabling us to provide personalized content. You are free to set your cookie preferences at your will.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close